linoleic acidWhat was measured
Measured, with no finding
299 endpoints
Show what was measuredHide what was measured
All-cause mortality
increases, p = 0.051
an increased risk of all cause mortality (17.6% v 11.8%; hazard ratio 1.62 (95% confidence interval 1.00 to 2.64); P=0.051)
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.05, n = 207
LA:SFA ratio (per 1 unit increase) | 1 | 1.51 (1.00 to 2.30) | 0.05 | 1.59 (1.04 to 2.43) | 0.03 | 1.44 (0.93 to 2.23) | 0.11
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.04, n = 207
2 | 1.55 (1.01 to 2.36) | 0.04 | 1.62 (1.05 to 2.48) | 0.03 | 1.47 (0.94 to 2.29) | 0.09
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.05, n = 207
PUFA (LA specific; per 5 en% increase) | 1 | 1.31 (1.00 to 1.71) | 0.05 | 1.37 (1.04 to 1.79) | 0.03 | 1.20 (0.90 to 1.59) | 0.22
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.05, n = 207
2 | 1.29 (1.00 to 1.67) | 0.05 | 1.35 (1.03 to 1.75) | 0.03 | 1.21 (0.91 to 1.61) | 0.19
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.66, n = 222
PUFA:SFA ratio (per 1 unit increase) | 1 | 0.84 (0.39 to 1.80) | 0.66 | 0.78 (0.36 to 1.70) | 0.53 | 0.56 (0.27 to 1.18) | 0.13
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.04, n = 429
PUFA:SFA ratio (per 1 unit increase) | 1 | 1.35 (1.01 to 1.80) | 0.04 | 1.39 (1.03 to 1.87) | 0.03 | 1.27 (0.93 to 1.73) | 0.14
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.88, n = 222
2 | 1.05 (0.56 to 1.97) | 0.88 | 1.00 (0.52 to 1.93) | 0.99 | 0.77 (0.39 to 1.52) | 0.46
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.01, n = 429
2 | 1.53 (1.14 to 2.05) | <0.01 | 1.58 (1.17 to 2.13) | <0.01 | 1.44 (1.04 to 1.98) | 0.03
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.28, n = 222
SFA (per 5 en% increase) | 1 | 0.77 (0.48 to 1.24) | 0.28 | 0.89 (0.54 to 1.47) | 0.65 | 0.98 (0.58 to 1.65) | 0.93
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.18, n = 207
SFA (per 5 en% increase) | 1 | 0.77 (0.52 to 1.13) | 0.18 | 0.77 (0.52 to 1.13) | 0.18 | 0.74 (0.50 to 1.11) | 0.15
PMID 23386268 · one of two readings recorded this
All-cause mortality
decreases, p = 0.03, n = 429
SFA (per 5 en% increase) | 1 | 0.74 (0.57 to 0.97) | 0.03 | 0.77 (0.58 to 1.01) | 0.06 | 0.77 (0.58 to 1.03) | 0.08
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.25, n = 222
2 | 0.76 (0.48 to 1.21) | 0.25 | 0.86 (0.53 to 1.39) | 0.54 | 0.95 (0.57 to 1.58) | 0.84
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.29, n = 207
2 | 0.81 (0.56 to 1.19) | 0.29 | 0.82 (0.56 to 1.21) | 0.31 | 0.78 (0.52 to 1.16) | 0.22
PMID 23386268 · one of two readings recorded this
All-cause mortality
decreases, p = 0.01, n = 429
2 | 0.70 (0.53 to 0.91) | <0.01 | 0.72 (0.54 to 0.95) | 0.02 | 0.72 (0.54 to 0.97) | 0.03
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.71, n = 222
PUFA (unspecified; per 5 en% increase) | 1 | 1.08 (0.71 to 1.66) | 0.71 | 1.07 (0.69 to 1.67) | 0.75 | 1.00 (0.62 to 1.61) | 0.99
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.02, n = 429
PUFA (unspecified; per 5 en% increase) | 1 | 1.26 (1.04 to 1.52) | 0.02 | 1.29 (1.07 to 1.57) | <0.01 | 1.19 (0.97 to 1.47) | 0.09
PMID 23386268 · one of two readings recorded this
All-cause mortality
no effect, p = 0.65, n = 222
2 | 1.10 (0.73 to 1.65) | 0.65 | 1.09 (0.72 to 1.66) | 0.68 | 1.02(0.65 to 1.60) | 0.93
PMID 23386268 · one of two readings recorded this
All-cause mortality
increases, p = 0.01, n = 429
2 | 1.31 (1.09 to 1.58) | <0.01 | 1.35 (1.12 to 1.63) | <0.01 | 1.26 (1.02 to 1.54) | 0.03
PMID 23386268 · one of two readings recorded this
Body mass index
no effect, p = 0.26
Body mass index | 25.4 (25.1 to 25.8) | 25.1 (24.8 to 25.3) | 24.5 (24.1 to 24.9) | 24.3 (24.0 to 24.6) | 0.26
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.037
cardiovascular mortality (17.2% v 11.0%; 1.70 (1.03 to 2.80); P=0.037)
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.03, n = 207
LA:SFA ratio (per 1 unit increase) | 1 | 1.51 (1.00 to 2.30) | 0.05 | 1.59 (1.04 to 2.43) | 0.03 | 1.44 (0.93 to 2.23) | 0.11
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.03, n = 207
2 | 1.55 (1.01 to 2.36) | 0.04 | 1.62 (1.05 to 2.48) | 0.03 | 1.47 (0.94 to 2.29) | 0.09
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.03, n = 207
PUFA (LA specific; per 5 en% increase) | 1 | 1.31 (1.00 to 1.71) | 0.05 | 1.37 (1.04 to 1.79) | 0.03 | 1.20 (0.90 to 1.59) | 0.22
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.03, n = 207
2 | 1.29 (1.00 to 1.67) | 0.05 | 1.35 (1.03 to 1.75) | 0.03 | 1.21 (0.91 to 1.61) | 0.19
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.53, n = 222
PUFA:SFA ratio (per 1 unit increase) | 1 | 0.84 (0.39 to 1.80) | 0.66 | 0.78 (0.36 to 1.70) | 0.53 | 0.56 (0.27 to 1.18) | 0.13
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.03, n = 429
PUFA:SFA ratio (per 1 unit increase) | 1 | 1.35 (1.01 to 1.80) | 0.04 | 1.39 (1.03 to 1.87) | 0.03 | 1.27 (0.93 to 1.73) | 0.14
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.99, n = 222
2 | 1.05 (0.56 to 1.97) | 0.88 | 1.00 (0.52 to 1.93) | 0.99 | 0.77 (0.39 to 1.52) | 0.46
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.01, n = 429
2 | 1.53 (1.14 to 2.05) | <0.01 | 1.58 (1.17 to 2.13) | <0.01 | 1.44 (1.04 to 1.98) | 0.03
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.65, n = 222
SFA (per 5 en% increase) | 1 | 0.77 (0.48 to 1.24) | 0.28 | 0.89 (0.54 to 1.47) | 0.65 | 0.98 (0.58 to 1.65) | 0.93
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.18, n = 207
SFA (per 5 en% increase) | 1 | 0.77 (0.52 to 1.13) | 0.18 | 0.77 (0.52 to 1.13) | 0.18 | 0.74 (0.50 to 1.11) | 0.15
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.06, n = 429
SFA (per 5 en% increase) | 1 | 0.74 (0.57 to 0.97) | 0.03 | 0.77 (0.58 to 1.01) | 0.06 | 0.77 (0.58 to 1.03) | 0.08
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.54, n = 222
2 | 0.76 (0.48 to 1.21) | 0.25 | 0.86 (0.53 to 1.39) | 0.54 | 0.95 (0.57 to 1.58) | 0.84
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.31, n = 207
2 | 0.81 (0.56 to 1.19) | 0.29 | 0.82 (0.56 to 1.21) | 0.31 | 0.78 (0.52 to 1.16) | 0.22
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
decreases, p = 0.02, n = 429
2 | 0.70 (0.53 to 0.91) | <0.01 | 0.72 (0.54 to 0.95) | 0.02 | 0.72 (0.54 to 0.97) | 0.03
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.75, n = 222
PUFA (unspecified; per 5 en% increase) | 1 | 1.08 (0.71 to 1.66) | 0.71 | 1.07 (0.69 to 1.67) | 0.75 | 1.00 (0.62 to 1.61) | 0.99
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.01, n = 429
PUFA (unspecified; per 5 en% increase) | 1 | 1.26 (1.04 to 1.52) | 0.02 | 1.29 (1.07 to 1.57) | <0.01 | 1.19 (0.97 to 1.47) | 0.09
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
no effect, p = 0.68, n = 222
2 | 1.10 (0.73 to 1.65) | 0.65 | 1.09 (0.72 to 1.66) | 0.68 | 1.02(0.65 to 1.60) | 0.93
PMID 23386268 · one of two readings recorded this
Cardiovascular mortality
increases, p = 0.01, n = 429
2 | 1.31 (1.09 to 1.58) | <0.01 | 1.35 (1.12 to 1.63) | <0.01 | 1.26 (1.02 to 1.54) | 0.03
PMID 23386268 · one of two readings recorded this
Triglycerides
no effect, p = 0.06
Triglycerides (mg/dL; 1 mg/dL=0.011 mmol/L) | 185.9 (168.8 to 202.9) | 189.0 (162.6 to 215.4) | 151.8 (133.9 to 169.7) | 135.5 (126.0 to 145.1) | 0.06
PMID 23386268 · one of two readings recorded this
all cause mortality (primary), cardiovascular mortality and coronary heart disease mortality, intention-to-treat Kaplan-Meier and Cox hazard ratios, Sydney Diet Heart Study
increases, all cause mortality HR 1.62 (95% CI 1.00 to 2.64), 17.6% v 11.8%, p = 0.051
Not recorded as a finding: the intervention held more than the compound
Compared with the control group, the intervention group had an increased risk of all cause mortality (17.6% v 11.8%; hazard ratio 1.62 (95% confidence interval 1.00 to 2.64); P=0.051), cardiovascular mortality (17.2% v 11.0%; 1.70 (1.03 to 2.80); P=0.037), and mortality from coronary heart disease (16.3% v 10.1%; 1.74 (1.04 to 2.92); P=0.036) (fig 2).
PMID 23386268 · one of two readings recorded this
Cardiovascular death, alcohol light stratum
no effect, p = 0.71, n = 71
Light (<200 kcal/day) | 71 | 1.09 (0.69 to 1.72) | 0.71
PMID 23386268 · one of two readings recorded this
Cardiovascular death, alcohol light stratum
increases, p = 0.05, n = 150
Light (<200 kcal/day) | 150 | 1.43 (1.00 to 2.04) | 0.05
PMID 23386268 · one of two readings recorded this
Cardiovascular death, alcohol moderate/heavy stratum
increases, p = 0.01, n = 79
Moderate/heavy (>200 kcal/day) | 79 | 1.70 (1.18 to 2.46) | <0.01
PMID 23386268 · one of two readings recorded this
Cardiovascular death, alcohol moderate/heavy stratum
increases, p = 0.01, n = 162
Moderate/heavy (>200 kcal/day) | 162 | 1.66 (1.23 to 2.25) | <0.01
PMID 23386268 · one of two readings recorded this
Cardiovascular death, alcohol none stratum
no effect, p = 0.25, n = 57
None | 57 | 1.40 (0.79 to 2.50) | 0.25
PMID 23386268 · one of two readings recorded this
Cardiovascular death, alcohol none stratum
no effect, p = 0.6, n = 117
None | 117 | 0.91 (0.65 to 1.28) | 0.60
PMID 23386268 · one of two readings recorded this
Cardiovascular death, non-smokers
no effect, p = 0.75, n = 60
No | 60 | 1.08 (0.67 to 1.68) | 0.75
PMID 23386268 · one of two readings recorded this
Cardiovascular death, non-smokers
no effect, p = 0.62, n = 128
No | 128 | 1.08 (0.79 to 1.49) | 0.62
PMID 23386268 · one of two readings recorded this
Cardiovascular death, smokers
increases, p = 0.01, n = 147
Yes | 147 | 1.55 (1.12 to 2.12) | 0.01
PMID 23386268 · one of two readings recorded this
Cardiovascular death, smokers
increases, p = 0.01, n = 301
Yes | 301 | 1.46 (1.15 to 1.86) | <0.01
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
increases, p = 0.036
mortality from coronary heart disease (16.3% v 10.1%; 1.74 (1.04 to 2.92); P=0.036)
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.11, n = 207
LA:SFA ratio (per 1 unit increase) | 1 | 1.51 (1.00 to 2.30) | 0.05 | 1.59 (1.04 to 2.43) | 0.03 | 1.44 (0.93 to 2.23) | 0.11
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.09, n = 207
2 | 1.55 (1.01 to 2.36) | 0.04 | 1.62 (1.05 to 2.48) | 0.03 | 1.47 (0.94 to 2.29) | 0.09
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.22, n = 207
PUFA (LA specific; per 5 en% increase) | 1 | 1.31 (1.00 to 1.71) | 0.05 | 1.37 (1.04 to 1.79) | 0.03 | 1.20 (0.90 to 1.59) | 0.22
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.19, n = 207
2 | 1.29 (1.00 to 1.67) | 0.05 | 1.35 (1.03 to 1.75) | 0.03 | 1.21 (0.91 to 1.61) | 0.19
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.13, n = 222
PUFA:SFA ratio (per 1 unit increase) | 1 | 0.84 (0.39 to 1.80) | 0.66 | 0.78 (0.36 to 1.70) | 0.53 | 0.56 (0.27 to 1.18) | 0.13
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.14, n = 429
PUFA:SFA ratio (per 1 unit increase) | 1 | 1.35 (1.01 to 1.80) | 0.04 | 1.39 (1.03 to 1.87) | 0.03 | 1.27 (0.93 to 1.73) | 0.14
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.46, n = 222
2 | 1.05 (0.56 to 1.97) | 0.88 | 1.00 (0.52 to 1.93) | 0.99 | 0.77 (0.39 to 1.52) | 0.46
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
increases, p = 0.03, n = 429
2 | 1.53 (1.14 to 2.05) | <0.01 | 1.58 (1.17 to 2.13) | <0.01 | 1.44 (1.04 to 1.98) | 0.03
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.93, n = 222
SFA (per 5 en% increase) | 1 | 0.77 (0.48 to 1.24) | 0.28 | 0.89 (0.54 to 1.47) | 0.65 | 0.98 (0.58 to 1.65) | 0.93
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.15, n = 207
SFA (per 5 en% increase) | 1 | 0.77 (0.52 to 1.13) | 0.18 | 0.77 (0.52 to 1.13) | 0.18 | 0.74 (0.50 to 1.11) | 0.15
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.08, n = 429
SFA (per 5 en% increase) | 1 | 0.74 (0.57 to 0.97) | 0.03 | 0.77 (0.58 to 1.01) | 0.06 | 0.77 (0.58 to 1.03) | 0.08
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.84, n = 222
2 | 0.76 (0.48 to 1.21) | 0.25 | 0.86 (0.53 to 1.39) | 0.54 | 0.95 (0.57 to 1.58) | 0.84
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.22, n = 207
2 | 0.81 (0.56 to 1.19) | 0.29 | 0.82 (0.56 to 1.21) | 0.31 | 0.78 (0.52 to 1.16) | 0.22
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
decreases, p = 0.03, n = 429
2 | 0.70 (0.53 to 0.91) | <0.01 | 0.72 (0.54 to 0.95) | 0.02 | 0.72 (0.54 to 0.97) | 0.03
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.99, n = 222
PUFA (unspecified; per 5 en% increase) | 1 | 1.08 (0.71 to 1.66) | 0.71 | 1.07 (0.69 to 1.67) | 0.75 | 1.00 (0.62 to 1.61) | 0.99
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.09, n = 429
PUFA (unspecified; per 5 en% increase) | 1 | 1.26 (1.04 to 1.52) | 0.02 | 1.29 (1.07 to 1.57) | <0.01 | 1.19 (0.97 to 1.47) | 0.09
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
no effect, p = 0.93, n = 222
2 | 1.10 (0.73 to 1.65) | 0.65 | 1.09 (0.72 to 1.66) | 0.68 | 1.02(0.65 to 1.60) | 0.93
PMID 23386268 · one of two readings recorded this
Coronary heart disease mortality
increases, p = 0.03, n = 429
2 | 1.31 (1.09 to 1.58) | <0.01 | 1.35 (1.12 to 1.63) | <0.01 | 1.26 (1.02 to 1.54) | 0.03
PMID 23386268 · one of two readings recorded this
Diastolic blood pressure
no effect, p = 0.38
Diastolic blood pressure (mm Hg) | 88.5 (86.9 to 90.0) | 88.5 (86.9 to 90.2) | 87.9 (86.0 to 89.9) | 87.5 (85.7 to 89.3) | 0.38
PMID 23386268 · one of two readings recorded this
Dietary alcohol intake (median)
no effect, p = 0.42
Alcohol‡ | 2.3 (0.0-8.1) | 2.4 (0.0-8.9) | 4.0 (0.9-8.7) | +1.7 | 3.1 (0.7-8.9) | +0.7 | 0.42
PMID 23386268 · one of two readings recorded this
Dietary carbohydrate intake (median)
no effect, p = 0.31
Carbohydrate‡ | 40.5 (37.0-45.2) | 39.9 (35.2-46.1) | 40.6 (35.6-44.8) | +0.1 | 41.3 (36.1-46.3) | +1.4 | 0.31
PMID 23386268 · one of two readings recorded this
Dietary cholesterol intake (median)
decreases, p = 0.001
Cholesterol (mg/day) | 439 (344-593) | 477 (355-621) | 331 (269-408) | −108 | 238 (203-283) | −239 | <0.001
PMID 23386268 · one of two readings recorded this
Dietary energy intake (median)
no effect, p = 0.07
Energy (kcal/day; 1 kcal=4.18 kJ) | 2384 (2072-2770) | 2423 (1972-2860) | 2194 (1804-2524) | −190 | 2256 (1958-2574) | −167 | 0.07
PMID 23386268 · one of two readings recorded this
Dietary MUFA intake (median)
decreases, p = 0.001
MUFA‡ | 14.7 (12.8-16.9) | 14.6 (13.2-16.5) | 14.0 (12.3-15.2) | −0.7 | 11.2 (10.1-12.7) | −3.4 | <0.001
PMID 23386268 · one of two readings recorded this
Dietary protein intake (median)
no effect, p = 0.25
Protein‡ | 14.1 (12.4-16.3) | 14.4 (12.6-16.5) | 15.3 (13.4-17.3) | +1.2 | 14.8 (13.4-16.8) | +0.4 | 0.25
PMID 23386268 · one of two readings recorded this
Dietary PUFA intake (median)
increases, p = 0.001
PUFA‡ | 6.2 (3.2-9.2) | 6.1 (3.0-9.2) | 8.4 (6.7-10.9) | +2.2 | 15.4 (12.3-17.9) | +9.3§ | <0.001
PMID 23386268 · one of two readings recorded this
Dietary PUFA:SFA ratio (median)
increases, p = 0.001
PUFA:SFA ratio | 0.41 (0.18-0.68) | 0.38 (0.16-0.65) | 0.63 (0.45-0.92) | +0.22 | 1.72 (1.31-2.08) | +1.34 | <0.001
PMID 23386268 · one of two readings recorded this
Dietary SFA intake (median)
decreases, p = 0.001
SFA‡ | 15.6 (13.0-18.7) | 16.2 (13.4-19.3) | 13.5 (11.4-15.6) | −2.1 | 9.3 (8.2-10.9) | −6.9 | <0.001
PMID 23386268 · one of two readings recorded this
Dietary total fat intake (median)
no effect, p = 0.87
Total fat‡ | 39.2 (35.0-43.5) | 40.2 (36.6-43.4) | 38.1 (34.3-41.2) | −1.1 | 38.3 (36.1-46.3) | −1.9 | 0.87
PMID 23386268 · one of two readings recorded this
mortality from coronary heart disease, hazard ratio intervention versus control
increases, 16.3% v 10.1%; 1.74 (1.04 to 2.92), p = 0.036
Not recorded as a finding: The list has no CHD-death node; the same sentence carries the all-cause and cardiovascular figures that were extracted
Compared with the control group, the intervention group had an increased risk of all cause mortality (17.6% v 11.8%; hazard ratio 1.62 (95% confidence interval 1.00 to 2.64); P=0.051), cardiovascular mortality (17.2% v 11.0%; 1.70 (1.03 to 2.80); P=0.037), and mortality from coronary heart disease (16.3% v 10.1%; 1.74 (1.04 to 2.92); P=0.036) (fig 2).
PMID 23386268 · one of two readings recorded this
Serum total cholesterol, percent change
decreases, p = 0.001
Serum total cholesterol decreased more in the LA intervention group than in the control group (−13.3% v −5.5%; P<0.001)
PMID 23386268 · one of two readings recorded this
Systolic blood pressure
no effect, p = 0.49
Systolic blood pressure (mm Hg) | 136.9 (134.2 to 139.6) | 136.6 (133.9 to 139.3) | 136.5 (133.4 to 139.5) | 136.4 (133.8 to 139.0) | 0.49
PMID 23386268 · one of two readings recorded this
Total cholesterol
decreases, p = 0.001
Total cholesterol (mg/dL; 1 mg/dL=0.026 mmol/L) | 282.0 (274.8 to 289.1) | 281.3 (272.9 to 289.7) | 266.5 (259.1 to 273.8) | 243.9 (237.4 to 250.4) | <0.001
PMID 23386268 · one of two readings recorded this
triglycerides, BMI and systolic and diastolic blood pressure between arms
no effect, no significant differences between groups at baseline or follow-up
Not recorded as a finding: Sentence names no compound or arm (agentless), so it does not support a claim on its own
There were no significant differences between groups in triglycerides, body mass index, or systolic or diastolic blood pressure at baseline or during follow-up.
PMID 23386268 · one of two readings recorded this
CHD deaths, dose-response per 5% of energy from LA
decreases
a 13% lower risk of CHD deaths (RR, 0.87; 95% CI, 0.81–0.93; Figure 7)
PMID 25161045 · one of two readings recorded this
CHD deaths, highest vs lowest category of dietary LA intake
decreases
The fixed-effect summary of RR for comparing the highest with lowest category was 0.79 (95% CI, 0.71–0.89; Figure 3)
PMID 25161045 · one of two readings recorded this
CHD deaths, substituting 5% energy from LA for carbohydrates
decreases
an 13% lower risk of CHD deaths (RR, 0.87; 95% CI, 0.81–0.94; Supplemental Figure S3)
PMID 25161045 · one of two readings recorded this
CHD deaths, substituting 5% energy from LA for saturated fat
decreases
an 13% lower risk of CHD deaths when substituting for the same amount of energy from SFAs (RR, 0.87; 95% CI, 0.82–0.94; Supplemental Figure S4)
PMID 25161045 · one of two readings recorded this
CHD events, dose-response per 5% of energy from LA
decreases
An increment of 5% of energy intake from LA was associated with a 10% lower risk of CHD events (RR, 0.90; 95% CI, 0.85–0.94; I2 = 44.6%; Figure 6)
PMID 25161045 · one of two readings recorded this
CHD events, substituting 5% energy from LA for carbohydrates
decreases
the risk estimate for substituting 5% energy intake from LA for carbohydrates was 0.90 (95% CI, 0.85–0.94; I2 = 47.3%; Supplemental Figure S1) with a fixed-effect model
PMID 25161045 · one of two readings recorded this
CHD events, substituting 5% energy from LA for carbohydrates
decreases
and 0.89 (95% CI, 0.80–0.98) with a random-effects model
PMID 25161045 · one of two readings recorded this
CHD events, substituting 5% energy from LA for saturated fat
decreases
the risk estimate for substituting 5% energy intake from LA for SFAs was 0.91 (95% CI, 0.87–0.96; I2 = 55.9%; Supplemental Figure S2) with a fixed-effect model
PMID 25161045 · one of two readings recorded this
CHD events, substituting 5% energy from LA for saturated fat
no effect
and 0.90 (95% CI, 0.80–1.01) with a random-effects model
PMID 25161045 · one of two readings recorded this
coronary heart disease deaths, pooled RR highest versus lowest dietary LA intake
decreases
Not recorded as a finding: Node requires incident CHD events; CHD death alone is a narrower endpoint and no node matches (cardiovascular mortality requires CVD as underlying cause).
Among 11 cohort studies (12 estimates) that examined the association between LA and CHD deaths, higher LA intake was associated with a lower risk of CHD deaths.
PMID 25161045 · both readings recorded this
Non-linearity test of LA intake and CHD deaths
no effect, p = 0.72
CHD deaths (P=0.72 for non-linearity; Figure 5)
PMID 25161045 · one of two readings recorded this
Non-linearity test of LA intake and CHD events
no effect, p = 0.91
we found a linear association between LA intake and CHD events (P=0.91 for non-linearity; Figure 4)
PMID 25161045 · one of two readings recorded this
Publication bias (Begg's test), CHD deaths
no effect, p = 1
Begg's test suggested no evidence of publication bias for either CHD events (P = 0.25) or CHD deaths (P = 1.00)
PMID 25161045 · one of two readings recorded this
Publication bias (Begg's test), CHD events
no effect, p = 0.25
Begg's test suggested no evidence of publication bias for either CHD events (P = 0.25) or CHD deaths (P = 1.00)
PMID 25161045 · one of two readings recorded this
Total CHD events, highest vs lowest category of dietary LA intake
decreases
The fixed-effect summary of RR for comparing the highest with lowest category was 0.85 (95% CI, 0.78–0.92; Figure 2) with medium heterogeneity (I2 = 35.5%)
PMID 25161045 · one of two readings recorded this
Total CHD events, highest vs lowest category of dietary LA intake
decreases
This finding was similar using a random-effects model (RR, 0.86; 95% CI, 0.76–0.97)
PMID 25161045 · one of two readings recorded this
HDL cholesterol
no effect, p = 0.468
a non-significant decrease in HDL cholesterol (mean difference = -0.051; 95% CI -0.188, 0.086; P = 0.468)
PMID 25379623 · one of two readings recorded this
HDL cholesterol
no effect, p = 0.455
non-significantly increased HDL-C (mean difference = 0.075; 95% CI -0.121, 0.270; P=0.455)
PMID 25379623 · one of two readings recorded this
LDL cholesterol
decreases, p = 0.002
a significant decrease in LDL cholesterol (mean difference = -0.218; 95% CI -0.358, -0.077; P = 0.002)
PMID 25379623 · one of two readings recorded this
LDL cholesterol
decreases, p = 0.028
significantly decreased LDL cholesterol (mean difference = -0.231; 95% CI -0.438, -0.024; P = 0.028)
PMID 25379623 · one of two readings recorded this
Total cholesterol
no effect, p = 0.896
a non-significant increase in total cholesterol (mean difference = 0.009; 95% CI -0.128, 0.146; P = 0.896)
PMID 25379623 · one of two readings recorded this
Total cholesterol
no effect, p = 0.124
non-significantly decreased total cholesterol (mean difference = -0.158; 95% CI -0.349, 0.042; P = 0.124)
PMID 25379623 · one of two readings recorded this
Triacylglycerol (TAG)
no effect, p = 0.344
a non-significant decrease in TAG (mean difference = -0.065; 95% CI -0.20, 0.07; P = 0.344)
PMID 25379623 · one of two readings recorded this
Triacylglycerol (TAG)
no effect, p = 0.433
non-significantly decreased TAG (mean difference = -0.078; 95% CI -0.274, 0.117; P = 0.433)
PMID 25379623 · one of two readings recorded this
Diastolic blood pressure, pooled net change
no effect, p = 0.52
the pooled estimate of change in DBP was 0.69 mm Hg (95% CI: −1.41, 2.80; P = 0.52)
PMID 25889408 · one of two readings recorded this
Heterogeneity I2, diastolic BP meta-analysis
p = 0.03
with substantial heterogeneity across trials (I2 = 52.0%, P = 0.03)
PMID 25889408 · one of two readings recorded this
Heterogeneity I2, systolic BP meta-analysis
p = 0.25
without significant heterogeneity (I2 = 22.2%, P = 0.25)
PMID 25889408 · one of two readings recorded this
Meta-regression of DBP net change on baseline BP
no effect, p = 0.13
Baseline BP | −0.11 (−0.53, 0.30) | 0.54 | −0.23 (−0.61, 0.14) | 0.13
PMID 25889408 · one of two readings recorded this
Meta-regression of DBP net change on CLA dose
no effect, p = 0.14
Dose | −1.78 (−3.76, 0.20) | 0.07 | −1.32 (−3.20, 0.56) | 0.14
PMID 25889408 · one of two readings recorded this
Meta-regression of DBP net change on intervention duration
no effect, p = 0.32
Duration | −0.16 (−0.53, 0.20) | 0.32 | −0.19 (−0.61, 0.23) | 0.32
PMID 25889408 · one of two readings recorded this
Meta-regression of SBP net change on baseline BP
no effect, p = 0.54
Baseline BP | −0.11 (−0.53, 0.30) | 0.54 | −0.23 (−0.61, 0.14) | 0.13
PMID 25889408 · one of two readings recorded this
Meta-regression of SBP net change on CLA dose
no effect, p = 0.07
Dose | −1.78 (−3.76, 0.20) | 0.07 | −1.32 (−3.20, 0.56) | 0.14
PMID 25889408 · one of two readings recorded this
Meta-regression of SBP net change on intervention duration
no effect, p = 0.32
Duration | −0.16 (−0.53, 0.20) | 0.32 | −0.19 (−0.61, 0.23) | 0.32
PMID 25889408 · one of two readings recorded this
Sensitivity analysis, SBP pooled change, leave-one-out lower bound
no effect
yielded a range from 0.22 mm Hg (95% CI: −1.45, 1.90) to–0.27 mm Hg (95% CI:-2.83, 2.29)
PMID 25889408 · one of two readings recorded this
Sensitivity analysis, SBP pooled change, leave-one-out upper bound
no effect
yielded a range from 0.22 mm Hg (95% CI: −1.45, 1.90) to–0.27 mm Hg (95% CI:-2.83, 2.29)
PMID 25889408 · one of two readings recorded this
Systolic blood pressure, pooled net change
no effect, p = 0.98
The pooled estimate of change in SBP was −0.03 mm Hg (95% CI: −2.29, 2.24; P = 0.98)
PMID 25889408 · one of two readings recorded this
breast cancer risk, pooled relative risk for highest versus lowest level of dietary and serum linoleic acid in prospective cohort and nested case-control studies
pooled RR 0.98 (0.93, 1.04), highest versus lowest level
Not recorded as a finding: the direction is carried only as a signed number
Compared with the lowest level of linoleic acid, the pooled relative risk (RR; 95 % CI) of breast cancer was 0·98 (0·93, 1·04) for the highest level of linoleic acid.
PMID 26434699 · one of two readings recorded this
breast cancer risk, pooled relative risk highest versus lowest level of dietary and serum linoleic acid
pooled RR 0.98 (0.93, 1.04) highest versus lowest linoleic acid
Not recorded as a finding: a direction is stated and the estimate does not support it
Compared with the lowest level of linoleic acid, the pooled relative risk (RR; 95 % CI) of breast cancer was 0·98 (0·93, 1·04) for the highest level of linoleic acid.
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The risk of breast cancer decreased by 1 % (RR=0·99; 95 % CI 0·93, 1·05) for every 10 g/d increment in linoleic acid intake
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The pooled RR (95 % CI) for dietary and serum linoleic acid were 0·99 (0·92, 1·06) and 0·98 (0·88, 1·08), respectively
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
the pooled relative risk (RR; 95 % CI) of breast cancer was 0·98 (0·93, 1·04) for the highest level of linoleic acid
PMID 26434699 · one of two readings recorded this
Breast cancer risk
no effect
The pooled RR (95 % CI) for dietary and serum linoleic acid were 0·99 (0·92, 1·06) and 0·98 (0·88, 1·08), respectively
PMID 26434699 · one of two readings recorded this
alpha-Linolenic acid concentration
increases
68 (95 % CI 53, 84) % for ALA
PMID 26878105 · one of two readings recorded this
alpha-Linolenic acid concentration
increases
ALA (cis-9,12,15-18: 3) | 3·05 | 2·08, 4·02 | Large | Medium | High | Medium | Moderate
PMID 26878105 · one of two readings recorded this
alpha-Tocopherol concentration
increases
The MPD was 13 (95 % CI 1, 26) %
PMID 26878105 · one of two readings recorded this
alpha-Tocopherol concentration
increases
α-Tocopherol | 0·74 | 0·01, 1·47 | Moderate | Medium | Moderate | Medium | Low
PMID 26878105 · one of two readings recorded this
Arachidonic acid concentration
decreases
AA (cis-5,8,11,14-20: 4) | −0·98 | −1·95, 0 | Moderate | Medium | Poor | Strong | Very low
PMID 26878105 · one of two readings recorded this
beta-Carotene concentration
no effect
β-Carotene | 0·08 | −0·51, 0·67 | Small | Low | Moderate | No | Moderate
PMID 26878105 · one of two readings recorded this
Carotenoids concentration
no effect
Carotenoids | 0·69 | −0·73, 2·1 | Moderate | High | Poor | No | Low
PMID 26878105 · one of two readings recorded this
CLA10 (trans-10, cis-12-18:2) concentration
no effect
CLA10 (trans-10- cis-12-18: 2) | 1·20 | −1·03, 3·43 | Large | Medium | Poor | Medium | Low
PMID 26878105 · one of two readings recorded this
CLA9 (cis-9, trans-11-18:2) concentration
increases
24 (95 % CI 8, 39) % for CLA9
PMID 26878105 · one of two readings recorded this
CLA9 (cis-9, trans-11-18:2) concentration
increases
CLA9 (cis-9- trans-11-18: 2) | 1·22 | 0·5, 1·95 | Large | Low | Moderate | Medium | Moderate
PMID 26878105 · one of two readings recorded this
DHA concentration
no effect
% for DPA and 21 (95 % CI −3, 47) % for DHA
PMID 26878105 · one of two readings recorded this
DHA concentration
no effect
DHA (cis-4,7,10,13,16,19-22: 6) | 0·21 | −0·26, 0·68 | Small | Low | High | No | Moderate
PMID 26878105 · one of two readings recorded this
DPA concentration
increases
45 (95 % CI 18, 71)
PMID 26878105 · one of two readings recorded this
DPA concentration
increases
DPA (cis-7,10,13,16,19-22: 5) | 1·24 | 0·37, 2·12 | Large | Low | Moderate | Medium | Moderate
PMID 26878105 · one of two readings recorded this
EPA concentration
increases
67 (95 % CI 32, 102) % for EPA
PMID 26878105 · one of two readings recorded this
EPA concentration
increases
EPA (cis-5,8,11,14,17-20: 5) | 1·31 | 0·56, 2·06 | Large | Medium | Moderate | Medium | Moderate
PMID 26878105 · one of two readings recorded this
Iodine concentration
decreases
−74 (95 % CI −115, −33)
PMID 26878105 · one of two readings recorded this
Iodine concentration
decreases
I | −1·20 | −1·8, −0·59 | Large | Low | Moderate | No | High
PMID 26878105 · one of two readings recorded this
Iron concentration
increases
20 (95 % CI 0, 41) % for Fe
PMID 26878105 · one of two readings recorded this
Iron concentration
increases
Fe | 0·37 | 0·03, 0·71 | Moderate | Low | High | No | High
PMID 26878105 · one of two readings recorded this
Lauric acid (12:0) concentration
no effect
12: 0 (lauric acid) | 0·18 | −1·39, 1·75 | Small | High | Poor | Medium | Very low
PMID 26878105 · one of two readings recorded this
Linoleic acid (cis-9,12-18:2) concentration
no effect
LA (cis-9,12-18: 2) | −0·92 | −1·96, 0·11 | Moderate | Medium | Poor | Medium | Low
PMID 26878105 · one of two readings recorded this
Lutein concentration
no effect
Lutein | 0·85 | −0·98, 2·68 | Large | Medium | Poor | No | Moderate
PMID 26878105 · one of two readings recorded this
Milk yield per cow
decreases
significantly lower in organic (−23; 95 % CI −31, −15 %) compared with conventional
PMID 26878105 · one of two readings recorded this
Milk yield
decreases
Milk yield | −1·23 | −1·64, −0·81 | Large | Medium | High | No | High
PMID 26878105 · one of two readings recorded this
Myristic acid (14:0) concentration
no effect
14: 0 (myristic acid) | 0·32 | −0·42, 1·05 | Small | High | Moderate | Medium | Very low
PMID 26878105 · one of two readings recorded this
n-3:n-6 ratio
increases
n-3: n-6 Ratio | 1·50 | 0·81, 2·19 | Large | Low | Moderate | Medium | Moderate
PMID 26878105 · one of two readings recorded this
n-6:n-3 ratio
decreases
n-6: n-3 Ratio | −2·26 | −4·34, −0·18 | Large | High | Poor | Medium | Low
PMID 26878105 · one of two readings recorded this
Oleic acid (cis-9-18:1) concentration
no effect
OA (cis-9-18: 1) | 0·28 | −0·64, 1·2 | Small | Low | Poor | Medium | Low
PMID 26878105 · one of two readings recorded this
Palmitic acid (16:0) concentration
no effect
16: 0 (palmitic acid) | −0·50 | −1·17, 0·17 | Moderate | Medium | Moderate | Strong | Low
PMID 26878105 · one of two readings recorded this
Selenium concentration
decreases
% for I and −21 (95 % CI −49, 6) % for Se
PMID 26878105 · one of two readings recorded this
Selenium concentration
decreases
Se | −0·49 | −0·89, −0·1 | Moderate | Low | High | Medium | Moderate
PMID 26878105 · one of two readings recorded this
Somatic cell count
no effect
SCC | 0·20 | −0·43, 0·82 | Small | Medium | Moderate | Medium | Low
PMID 26878105 · one of two readings recorded this
Total CLA concentration
increases
The MPD were 41 (95 % CI 14, 68) % for total CLA
PMID 26878105 · one of two readings recorded this
Total CLA concentration
increases
CLA (total) | 1·40 | 0·37, 2·42 | Large | Medium | Moderate | Medium | Moderate
PMID 26878105 · one of two readings recorded this
Total MUFA concentration
no effect
MUFA | 0·18 | −0·4, 0·76 | Small | Medium | Moderate | Strong | Very low
PMID 26878105 · one of two readings recorded this
Total n-3 FA concentration
increases
n-3 FA | 2·18 | 1·11, 3·25 | Large | Low | Moderate | Medium | Moderate
PMID 26878105 · one of two readings recorded this
Total n-3 PUFA concentration
increases
The MPD was 56 (95 % CI 38, 74) % for total n-3
PMID 26878105 · one of two readings recorded this
Total n-6 FA concentration
no effect
n-6 FA | −0·06 | −0·97, 0·86 | Small | High | Moderate | Medium | Very low
PMID 26878105 · one of two readings recorded this
Total PUFA concentration
increases
with an MPD of 7·3 (95 % CI −0·7, 15) %
PMID 26878105 · one of two readings recorded this
Total PUFA concentration
increases
PUFA | 0·88 | 0·19, 1·56 | Large | Medium | Moderate | No | Moderate
PMID 26878105 · one of two readings recorded this
Total SFA concentration
no effect
SFA | −0·17 | −0·66, 0·31 | Small | Medium | High | Strong | Low
PMID 26878105 · one of two readings recorded this
Total VLC n-3 PUFA (EPA+DPA+DHA) concentration
increases
an MPD of 57 (95 % CI 27, 87) %
PMID 26878105 · one of two readings recorded this
Urea concentration
no effect
Urea | −0·42 | −1·04, 0·19 | Moderate | Low | Moderate | No | Moderate
PMID 26878105 · one of two readings recorded this
Vaccenic acid concentration
increases
66 (95 % CI 20, 112)
PMID 26878105 · one of two readings recorded this
Vaccenic acid (trans-11-18:1) concentration
increases
VA (trans-11-18: 1) | 2·48 | 1·08, 3·87 | Large | Medium | Moderate | Medium | Moderate
PMID 26878105 · one of two readings recorded this
Cancer mortality
decreases
0.89 (95% CI: 0.85, 0.93; I2 = 0%) for cancer mortality
PMID 32020162 · one of two readings recorded this
Cancer mortality
decreases
0.91 (95% CI: 0.84, 0.98; I2 = 26.3%) for cancer mortality
PMID 32020162 · one of two readings recorded this
Cardiovascular disease mortality
decreases
0.87 (95% CI: 0.82, 0.92; I2 = 3.7%) for CVD mortality
PMID 32020162 · one of two readings recorded this
Cardiovascular disease mortality
decreases
0.89 (95% CI: 0.85, 0.94; I2 = 28.9%) for CVD mortality
PMID 32020162 · one of two readings recorded this
Total mortality
decreases
Pooled RRs comparing extreme categories of dietary LA intake (high vs low) were 0.87 (95% CI: 0.81, 0.94; I2 = 67.9%) for total mortality
PMID 32020162 · one of two readings recorded this
Total mortality
decreases
Pooled RRs for each SD increment in LA concentrations in adipose tissue/blood compartments were 0.91 (95% CI: 0.87, 0.95; I2 = 64.1%) for total mortality
PMID 32020162 · one of two readings recorded this
TNF-alpha
decreases, p = 0.011
found a significant reduction in TNF-α compared to placebo [(WMD = −0.99 mg/dl; 95% CI, −1.76 to −0.22; p = 0.011
PMID 36911696 · one of two readings recorded this
TNF-alpha
decreases, p = 0.001
intervention dose of <3 (g/day) (WMD = −3.08 mg/dl; 95% CI, −4.91 to −1.25; p = 0.001)
PMID 36911696 · one of two readings recorded this
TNF-alpha
decreases, p = 0.002
healthy people (WMD = −2.01 mg/dl; 95% CI, −3.31 to −0.71; p = 0.002)
PMID 36911696 · one of two readings recorded this
TNF-alpha
decreases, p = 0.033
male subjects (WMD = −1.01 mg/dl; 95% CI, −1.95 to −0.08; p = 0.033)
PMID 36911696 · one of two readings recorded this
TNF-alpha
decreases, p = 0.002
when a mixture of two isomers was used (WMD = −1.41 mg/dl; 95% CI, −2.31 to −0.50; p = 0.002)
PMID 36911696 · one of two readings recorded this
TNF-alpha
decreases, p = 0.048
subjects with normal range of BMI (18.5–24.9) (WMD = −9.29 mg/dl; 95% CI, −18.51 to −0.08; p = 0.048)
PMID 36911696 · one of two readings recorded this
TNF-alpha
increases, p = 0.001
TNF-α was significantly increased (WMD = 1.29 mg/dl; 95% CI, 0.64 to 1.93; p < 0.001)
PMID 36911696 · one of two readings recorded this
Adiponectin publication bias (Begg's test)
no effect, p = 0.198
no significant publication bias was detected according to Begg’s test for most of the variables, such as CRP (p = 0.189), IL-6 (p = 0.441), adiponectin (p = 0.198), and leptin (p = 0.050)
PMID 36911696 · one of two readings recorded this
Adiponectin
no effect, p = 0.976
CLA supplementation had no significant effect on adiponectin level in the intervention group compared to placebo [(WMD = −0.01 mg/dl; 95% CI, −0.68 to 0.71; p = 0.976
PMID 36911696 · one of two readings recorded this
Adiponectin
decreases, p = 0.001
a significant decrease in adiponectin levels in the female subjects (WMD = −1.05 mg/dl; 95% CI, −1.58 to −0.52; p < 0.001)
PMID 36911696 · one of two readings recorded this
C-reactive protein
increases, p = 0.048
significantly increased CRP compared to placebo [(WMD = 0.26 mg/dl; 95% CI, 0.00 to 0.52; p = 0.048
PMID 36911696 · one of two readings recorded this
C-reactive protein
increases, p = 0.017
supplementation dose ≥3 (g/day) (WMD = 0.49 mg/dl; 95% CI, 0.09 to 0.90; p = 0.017)
PMID 36911696 · one of two readings recorded this
C-reactive protein
increases, p = 0.016
The effect of CLA on CRP was significant in studies with baseline CRP less than 3 mg/dl (WMD = 0.31 mg/dl; 95% CI, 0.05 to 0.57; p = 0.016)
PMID 36911696 · one of two readings recorded this
C-reactive protein
increases, p = 0.008
and healthy subgroup (WMD = 0.39 mg/dl; 95% CI, 0.10 to 0.68; p = 0.008)
PMID 36911696 · one of two readings recorded this
CRP publication bias (Begg's test)
no effect, p = 0.189
no significant publication bias was detected according to Begg’s test for most of the variables, such as CRP (p = 0.189), IL-6 (p = 0.441), adiponectin (p = 0.198), and leptin (p = 0.050)
PMID 36911696 · one of two readings recorded this